LC
CVS icon

Lindbrook Capital’s CVS Health CVS Stock Holding History

Lindbrook Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$589K Buy
8,688
+1,916
+28% +$115K 0.05% 198
2024
Q4 		$304K Buy
6,772
+248
+4% +$13.9K 0.03% 308
2024
Q3 		$410K Buy
6,524
+527
+9% +$30.7K 0.04% 249
2024
Q2 		$354K Sell
5,997
-2,047
-25% -$128K 0.03% 256
2024
Q1 		$642K Sell
8,044
-969
-11% -$74K 0.06% 182
2023
Q4 		$712K Buy
9,013
+2,351
+35% +$167K 0.07% 155
2023
Q3 		$465K Buy
6,662
+445
+7% +$31.5K 0.05% 190
2023
Q2 		$430K Sell
6,217
-851
-12% -$60.6K 0.05% 198
2023
Q1 		$525K Sell
7,068
-457
-6% -$38.3K 0.06% 164
2022
Q4 		$701K Sell
7,525
-34
-0.4% -$3.28K 0.09% 146
2022
Q3 		$721K Sell
7,559
-807
-10% -$79.9K 0.12% 103
2022
Q2 		$775K Buy
8,366
+3,484
+71% +$340K 0.13% 105
2022
Q1 		$494K Buy
4,882
+1,098
+29% +$115K 0.08% 163
2021
Q4 		$390K Buy
3,784
+668
+21% +$61.7K 0.06% 190
2021
Q3 		$264K Buy
3,116
+45
+1% +$3.77K 0.07% 121
2021
Q2 		$256K Hold
3,071
– – 0.06% 137
2021
Q1 		$231K Buy
3,071
+41
+1% +$2.99K 0.05% 138
2020
Q4 		$207K Sell
3,030
-16
-0.5% -$1.04K 0.05% 139
2020
Q3 		$178K Sell
3,046
-311
-9% -$19.4K 0.05% 134
2020
Q2 		$218K Buy
3,357
+1,048
+45% +$66K 0.06% 109
2020
Q1 		$137K Sell
2,309
-644
-22% -$43K 0.05% 146
2019
Q4 		$219K Sell
2,953
-301
-9% -$21.1K 0.08% 130
2019
Q3 		$205K Buy
3,254
+1,070
+49% +$63.4K 0.08% 130
2019
Q2 		$119K Buy
2,184
+733
+51% +$39.5K 0.05% 203
2019
Q1 		$78K Sell
1,451
-210
-13% -$13K 0.03% 277
2018
Q4 		$108K Buy
+1,661
New +$124K 0.05% 184

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lindbrook Capital's CVS Position: Q1 2025 in Review

Lindbrook Capital increased its CVS Health (CVS) stake by 28% in Q1 2025, buying an estimated $115K and bringing the position to 8,688 shares worth $589K. The position accounts for 0.05% of the portfolio, ranked #198.

Lindbrook Capital first reported a position in CVS in Q4 2018 and has held it in 26 quarters since. The position peaked at $775K in Q2 2022. 1,754 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Lindbrook Capital held 8,688 shares of CVS Health worth $589K as of Q1 2025.
  • Lindbrook Capital bought 1,916 CVS Health shares in Q1 2025, an estimated $115K.
  • CVS Health made up 0.05% of Lindbrook Capital's portfolio in Q1 2025, its #198 holding.
  • Lindbrook Capital first reported a position in CVS Health in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's CVS Health position peaked at $775K in Q2 2022.
  • 1,754 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.